Gö6976 reduced infection of HCT-8 cells with both C. parvum and C. hominis at nanomolar doses with an EC50 (half-maximal effective concentration) for inhibition of C. parvum infection coinciding with the reported Gö6976 half-maximal inhibitory concentration (IC50) for PKCα (31). This evidence concerns the gene PRKCA and infection.